MicroRNAs in cardiovascular disease

MicroRNAs in cardiovascular disease

Cardiovascular disease (CVD) remains the predominant cause of human morbidity and mortality in developed countries. Currently, microRNAs have been investigated in many diseases as well-promising biomarkers for diagnosis, prognosis, and disease monitoring. Plenty studies have been designed so as to e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hellenic journal of cardiology 2020-05, Vol.61 (3), p.165-173
Hauptverfasser: Siasos, Gerasimos, Bletsa, Evanthia, Stampouloglou, Panagiota K., Oikonomou, Evangelos, Tsigkou, Vasiliki, Paschou, Stavroula A., Vlasis, Konstantinos, Marinos, Georgios, Vavuranakis, Manolis, Stefanadis, Christodoulos, Tousoulis, Dimitris
Format: Artikel
Sprache:eng
Schlagworte:
Atherosclerosis
Biomarkers
Cardiovascular disease
MicroRNAs
Molecular cardiology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cardiovascular disease (CVD) remains the predominant cause of human morbidity and mortality in developed countries. Currently, microRNAs have been investigated in many diseases as well-promising biomarkers for diagnosis, prognosis, and disease monitoring. Plenty studies have been designed so as to elucidate the properties of microRNAs in the classification and risk stratification of patients with CVD and also to evaluate their potentials in individualized management and guide treatment decisions. Therefore, in this review article, we aimed to present the most recent data concerning the role of microRNAs as potential novel biomarkers for cardiovascular disease. [Display omitted]
ISSN:1109-9666
2241-5955
DOI:10.1016/j.hjc.2020.03.003